Drug recall · January 17, 2024
Vigabatrin for Oral Solution recall
Why: Defective Container: powder may leak out of the pouch
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Vigabatrin for Oral Solution, USP 500 mg per packet, 50 packets per box, Rx Only, Manufactured by: InvaGen Pharmaceuticals, Inc., (a subsidiary of Cipla Ltd.), Hauppauge, NY, 11788, Manufactured for: Cipla USA, Inc., Warren, NJ 07059, NDC 69097-964-53
- Lots / codes
Lot #: NB301030, Exp. Date 03/31/2025
- Quantity
- 1240 boxes
- Company
- InvaGen Pharmaceuticals, Inc., Central Islip, NY
- Distribution
- Nationwide within the United States
- Initiated
- November 17, 2023 · Voluntary: Firm initiated
- Classified
- January 8, 2024
- Reported
- January 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Vigabatrin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.